Cancer related cognitive impairment: a downside of cancer treatment
Cancer treatment is associated with long lasting cognitive impairment in cancer survivors.
This cognitive impairment is often termed cancer related cognitive impairment (CRCI) …
This cognitive impairment is often termed cancer related cognitive impairment (CRCI) …
Managing survivorship after hematopoietic cell transplantation
N Khera - Current Hematologic Malignancy Reports, 2023 - Springer
Abstract Purpose of Review With improvement in survival after hematopoietic cell
transplantation (HCT), it has become important to focus on the late complications …
transplantation (HCT), it has become important to focus on the late complications …
[HTML][HTML] American society for transplantation and cellular therapy return to work guidance committee recommendations for health care providers who take care of …
RB Salit, K Schoeppner, C De Biase… - … and Cellular Therapy, 2022 - Elsevier
Hematopoietic cell transplantation (HCT) health care providers report a desire to improve
long-term outcomes and quality of life for their patients. One of the items frequently cited by …
long-term outcomes and quality of life for their patients. One of the items frequently cited by …
Remote assessment of cognitive dysfunction in hematologic malignancies using web‐based neuropsychological testing
OY Franco‐Rocha, ML Mahaffey, W Matsui… - Cancer …, 2023 - Wiley Online Library
Background Cognitive impairment is a frequent adverse effect of cancer and its therapies. As
neuropsychological assessment is not often standard of care for patients with non‐CNS …
neuropsychological assessment is not often standard of care for patients with non‐CNS …
[HTML][HTML] The multifactorial model of cancer-related cognitive impairment
KR Oppegaard - Number 2/March 2023, 2023 - onf.ons.org
Problem Identification: Cancer-related cognitive impairment (CRCI) is common and is
associated with cancer and its treatments. Evidence suggests that the causes are …
associated with cancer and its treatments. Evidence suggests that the causes are …
Clinical relevance of brain MRI changes in primary central nervous system lymphoma after high-dose-chemotherapy and autologous stem cell transplantation
SA Beer, R Möhle, G Tabatabai, DA Merle… - Bone Marrow …, 2024 - nature.com
Primary central nervous system lymphoma (PCNSL) is a potentially curable disease, but
affected patients often struggle in everyday life due to disease-and therapy-associated …
affected patients often struggle in everyday life due to disease-and therapy-associated …
Delirium and healthcare utilization in patients undergoing hematopoietic stem cell transplantation
HL Amonoo, NH Markovitz, PC Johnson, A Kwok… - … and cellular therapy, 2023 - Elsevier
Delirium, a common neuropsychiatric syndrome among hospitalized patients, has been
associated with significant morbidity and mortality in patients undergoing hematopoietic …
associated with significant morbidity and mortality in patients undergoing hematopoietic …
Neurocognitive outcomes in pediatric hematological cancer survivors post‐HSCT: A systematic review
S Ansari, A Garg, MA Khan - Clinical Transplantation, 2024 - Wiley Online Library
Background Pediatric hematological cancer survivors who undergo hematopoietic stem cell
transplantation (HSCT) may experience long‐term neurocognitive impairments. This …
transplantation (HSCT) may experience long‐term neurocognitive impairments. This …
[HTML][HTML] A qualitative study of the everyday impacts of cognitive difficulties after stem cell transplantation
SJ Mayo - Number 4/July 2022, 2022 - ons.org
Purpose: To explore how cognitive difficulties affect the everyday lives of survivors of
allogeneic hematopoietic stem cell transplantation (allo-HSCT). Participants & Setting: 20 …
allogeneic hematopoietic stem cell transplantation (allo-HSCT). Participants & Setting: 20 …
Prevalence and clinical correlates of cognitive impairment in adults with plasma cell disorders
ZM Nakamura, SN Vohra, CE Jensen, KA Nyrop… - Journal of geriatric …, 2022 - Elsevier
Introduction Older adults with plasma cell disorders (PCDs) experience cognitive
dysfunction that may be attributable to the disease and associated therapies. Yet, this has …
dysfunction that may be attributable to the disease and associated therapies. Yet, this has …